Propofol suppresses lung cancer tumorigenesis by modulating the <scp>circ‐ERBB2</scp>/<scp>miR</scp>‐7‐5p/<scp>FOXM1</scp> axis

Abstract

Propofol inhibited lung cancer progression via mediating circ-ERBB2/miR-7-5p/FOXM1 axis, which might provide an effective therapeutic target for lung cancer therapy.